FTY720 Protects Against Ischemia–Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model
Open Access
- 27 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Stroke Research
- Vol. 11 (5), 1103-1116
- https://doi.org/10.1007/s12975-020-00789-x
Abstract
Injury due to brain ischemia followed by reperfusion (I/R) may be an important therapeutic target in the era of thrombectomy. FTY720, a widely known sphingosine-1-phosphate receptor agonist, exerts various neuroprotective effects. The aim of this study was to examine the protective effect of FTY720 with respect to I/R injury, especially focusing on blood–brain barrier (BBB) protection and anti-inflammatory effects. Male rats were subjected to transient ischemia and administered vehicle or 0.5 or 1.5 mg/kg of FTY720 immediately before reperfusion. Positron emission tomography (PET) with [18F]DPA-714 was performed 2 and 9 days after the insult to serially monitor neuroinflammation. Bovine and rat brain microvascular endothelial cells (MVECs) were also subjected to oxygen-glucose deprivation (OGD) and reperfusion, and administered FTY720, phosphorylated-FTY720 (FTY720-P), or their inhibitor. FTY720 dose-dependently reduced cell death, the infarct size, cell death including apoptosis, and inflammation. It also ameliorated BBB disruption and neurological deficits compared to in the vehicle group. PET indicated that FTY720 significantly inhibited the worsening of inflammation in later stages. FTY720-P significantly prevented the intracellular redistribution of tight junction proteins but did not increase their mRNA expression. These results suggest that FTY720 can ameliorate I/R injury by protecting the BBB and regulating neuroinflammation.Keywords
Funding Information
- Grant-in-Aids from the Ministry of Education, Science and Culture of Japan (16K19992)
- Japan Agency for Medical Research and Development (JP17bk0104045h)
This publication has 49 references indexed in Scilit:
- Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization TherapyOxidative Medicine and Cellular Longevity, 2018
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in StrokeThe New England Journal of Medicine, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeThe New England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionThe New England Journal of Medicine, 2015
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010The Lancet, 2013
- Neuroprotective mechanisms of hypothermia in brain ischaemiaNature Reviews Neuroscience, 2012
- Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitisInternational Immunopharmacology, 2011
- FTY720 Reduces Extracellular Matrix Expansion Associated With Ischemia-Reperfusion Induced InjuryTransplantation Proceedings, 2007
- FTY720 Attenuates Hepatic Ischemia-Reperfusion Injury in Normal and Cirrhotic LiversAmerican Journal of Transplantation, 2004
- Effect of Pretreatment with FTY720 and Cyclosporin on Ischaemia-Reperfusion Injury of the Liver in RatsJournal of Pharmacy and Pharmacology, 1999